La Crosse Method Protocol

January 25, 2017

Epinephrine and education: Perspectives using the La Crosse Method

By Michael B. Kachel, RPh, Allergychoices Pharmacy

With the recent controversy over skyrocketing EpiPen prices, more patients and providers are scrutinizing when—or whether—the life-saving epinephrine device is needed for use with sublingual immunotherapy using the La Crosse Method Protocol.

In the experience of the La Crosse Method Protocol authors, the safety of sublingual immunotherapy following […]

More »

, , ,

October 7, 2015

Three is the Key to Development of Allergic Tolerance

Author: Mary Morris, MD, ABIM

Three is the key…this number holds a lot of importance in what believe makes the La Crosse Method™ Protocol safe and effective long term.

First, three times a day. Every day. That’s been our daily mantra for dosing with allergy drops for decades. Many patients and providers ask […]

More »

, , , , ,

August 25, 2015

La Crosse Method Reviewed

Author: Mary Morris, MD, ABIM

In recent years, sublingual immunotherapy has continued to gain acceptance and understanding, leading to its international recognition as a viable alternative to subcutaneous injection for allergy in both adults and children.1 With the recent FDA approval of single antigen sublingual immunotherapy tablets, even more physicians are considering, referring or offering […]

More »

,

August 11, 2015

It’s all about the patient.

Author: Anne Hendrickson

That’s been the mantra at Allergychoices since day one, when our founder Dr. David Morris decided to make a critical step. For 30 years, his La Crosse, Wisconsin allergy practice was a destination for the typical allergy sufferers as well as “last resort” allergic patients who had tried most every treatment under […]

More »

,